Trial Profile
Feasability Study on the Use of Botulinum Toxin A in Primary Adductor Tendinopathies Refractory to Medical Treatment
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 05 May 2021
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Pain
- Focus Therapeutic Use
- Acronyms PETRA
- 16 May 2019 Planned End Date changed from 1 Oct 2020 to 2 Aug 2020.
- 16 May 2019 Planned primary completion date changed from 1 Oct 2020 to 2 Aug 2020.
- 16 May 2019 Status changed from not yet recruiting to recruiting.